TuHURA Biosciences (HURA) Stock Analysis
NASDAQHealthcareBiotechnology
What TuHURA Biosciences does
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
Key metrics
ETFs linked to HURA
Broad-market and Healthcare sector ETFs an investor holding TuHURA Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how HURA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HURA in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for TuHURA Biosciences?
- TuHURA Biosciences trades under the ticker HURA on NASDAQ.
- Which exchange is HURA listed on?
- HURA is listed on NASDAQ.
- What sector does TuHURA Biosciences operate in?
- TuHURA Biosciences is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze HURA in a portfolio?
- PortView shows HURA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.